As you might know, 10x Genomics, Inc. ( NASDAQ:TXG ) just kicked off its latest quarterly results with some very ...

Detailed price information for 10X Genomics Inc (TXG-Q) from The Globe and Mail including charting and trades.

PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results ...

Biotech company 10x Genomics (NASDAQ:TXG) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up ...

Genomics (TXG) delivered earnings and revenue surprises of 20% and 16.24%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

PLEASANTON, Calif. (AP) — PLEASANTON, Calif. (AP) — 10x Genomics Inc. (TXG) on Thursday reported a loss of $34.4 million in its first quarter. The Pleasanton, California-based company said it had a ...

Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today reported financial results for the first ...

Why are tensions escalating between India and Pakistan? Our team of BBC experts explain, after India launches missile strikes in Pakistan and Pakistan-administered Kashmir. Five Indian jets were ...

Smaller-scale trades involved Pacific Biosciences of California Inc (NASDAQ: PACB) and 10X Genomics Inc (NASDAQ: TXG ), with ARK purchasing 194,298 and 18,177 shares respectively, totaling $213,727 ...

Genomics (NASDAQ:TXG) is scheduled to announce Q1 earnings results on Thursday, May 8th, after market close. The consensus ...

The ARKK ETF also expanded its position in Natera Inc (NASDAQ: NTRA) by purchasing 55,623 shares, translating to an investment of around $8.75 million. This move suggests a growing interest in the ...

Short interest in 10x Genomics Inc (NASDAQ:TXG) increased during the last reporting period, rising from 12.06M to 12.86M. This put 17.73% of the company's publicly available shares short.